Patient-Centric Approaches in Oncology

Abstract

Patient-centric care in oncology represents a paradigm shift from disease-focused models to approaches prioritizing the individual needs, preferences, and values of cancer patients. This review synthesizes recent evidence and guideline-based recommendations on implementing patient-centered strategies in oncologic practice. The discussion encompasses epidemiology, pathophysiology, risk factors, clinical features, diagnosis, management, and recent advances, with an emphasis on clinical relevance and practical application for healthcare professionals. By integrating mechanistic insights and emerging therapies, the article highlights the transformative potential and ongoing challenges of true patient-centric oncology care.

Introduction

Oncology has witnessed a fundamental evolution from standardized, protocol-driven cancer treatment toward patient-centric models that prioritize the holistic well-being of individuals. Patient-centric care, as defined by the Institute of Medicine, emphasizes the provision of care that is respectful of, and responsive to, individual patient preferences, needs, and values, ensuring that patient values guide all clinical decisions. In oncology, this approach is particularly significant given the complexity, chronicity, and psychosocial impact of cancer diagnoses and treatments. This article provides a comprehensive review of patient-centric approaches in oncology, examining their scientific underpinnings, clinical utility, and integration into evidence-based practice.

Epidemiology / Disease Burden

Globally, cancer remains a leading cause of morbidity and mortality, with over 19 million new cases and nearly 10 million deaths in 2022 according to GLOBOCAN estimates. The heterogeneity of cancer types, clinical presentations, and outcomes underscores the necessity for individualized care. The rising incidence of cancer in aging populations, combined with improved survival rates due to diagnostic and therapeutic advances, has increased the prevalence of patients living with cancer as a chronic condition. This epidemiological landscape intensifies the demand for patient-centric care models that address not only survival outcomes but also quality of life, psychosocial well-being, and patient autonomy throughout the cancer continuum.

Pathophysiology

Cancer pathophysiology involves complex molecular and cellular mechanisms, including genetic mutations, dysregulated signaling pathways, immune evasion, and tumor microenvironment interactions. The variability in tumor biology among patients necessitates a nuanced approach to therapy selection and patient engagement. Molecular profiling and precision medicine have facilitated the development of targeted therapies tailored to individual tumor characteristics, reinforcing the need for patient-centric frameworks that integrate biological heterogeneity with patient values and treatment goals.

Risk Factors

Cancer risk is multifactorial, encompassing genetic predisposition (e.g., BRCA1/2 mutations), lifestyle factors (e.g., tobacco use, diet, physical inactivity), environmental exposures (e.g., carcinogens, radiation), and comorbidities. Patient-centric oncology care requires comprehensive risk assessment and shared decision-making, enabling patients to understand personalized risk profiles and participate in preventive strategies or early detection initiatives. This approach fosters patient empowerment and adherence to recommended interventions, ultimately supporting better outcomes.

Clinical Features

Presenting features of cancer are highly variable, ranging from asymptomatic early stages to advanced disease with significant symptom burden. Patient experience is shaped not only by tumor-related factors but also by psychological, social, and spiritual dimensions. A patient-centric approach necessitates thorough assessment of symptoms, distress, functional status, and patient-reported outcomes. Incorporating validated tools such as the Edmonton Symptom Assessment System (ESAS) and NCCN Distress Thermometer facilitates systematic evaluation of patient needs and guides individualized care plans.

Diagnosis

Accurate cancer diagnosis involves a multidisciplinary approach, utilizing imaging, histopathology, molecular testing, and staging procedures. Patient-centric diagnostics emphasize timely communication of results, patient education, and inclusion in the diagnostic process. Genetic counseling and decision aids are increasingly employed to support patients facing complex choices, such as germline testing or participation in biomarker-driven clinical trials. Engaging patients in diagnostic discussions enhances informed consent and satisfaction with care.

Treatment & Management

Oncologic treatment has become increasingly complex, encompassing surgery, radiation, systemic therapy (chemotherapy, targeted therapy, immunotherapy), and supportive care. Patient-centric management focuses on aligning treatment options with patient preferences, goals of care, and quality-of-life considerations. Shared decision-making is central, requiring transparent discussions about benefits, risks, side effects, and prognosis. Multidisciplinary care teams, including oncology nurses, palliative care specialists, mental health professionals, and social workers, collaborate to deliver holistic care. Symptom management, psychosocial support, survivorship planning, and advanced care planning are integral to comprehensive patient-centric oncology.

Recent Advances / Emerging Therapies

Recent years have seen significant advances in patient-centric oncology, including the integration of digital health tools, telemedicine, and patient-reported outcome measures (PROMs) into routine care. Precision oncology, informed by next-generation sequencing, is enabling individualized therapy selection. Immunotherapies, such as checkpoint inhibitors and CAR-T cell therapy, offer new hope for patients with historically poor prognoses. Enhanced recovery after surgery (ERAS) protocols, navigational programs, and supportive care innovations are improving patient experience and outcomes. Artificial intelligence (AI)-driven decision support and personalized care pathways are being piloted to further individualize cancer care.

Guideline Recommendations

Leading oncology societies, including ASCO, ESMO, and NCCN, advocate for patient-centric care as a fundamental principle. Guidelines recommend routine assessment of patient preferences, use of validated PROMs, integration of palliative care, and structured shared decision-making processes. Clinicians are encouraged to adopt communication strategies that foster trust and respect patient autonomy. National and international frameworks increasingly require demonstration of patient engagement and quality-of-life outcomes in clinical trials and real-world practice. Institutions are called to implement patient navigation, survivorship care planning, and multidisciplinary team approaches as standards of care.

Conclusion

Patient-centric approaches in oncology are transforming cancer care by shifting the focus from disease alone to the lived experience of each individual. This model improves clinical outcomes, enhances patient satisfaction, and addresses the multidimensional impact of cancer. As scientific understanding and therapeutic options expand, the imperative to deliver personalized, respectful, and value-driven care becomes ever more critical. Ongoing research, guideline development, and system-level innovation will be essential to fully realize the promise of patient-centric oncology in improving the lives of those affected by cancer.